Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Jul 27, 2026 12:23:14 PM EDT

176.57USD+0.458%(+0.80)432,643

176.10Bid 186.90Ask 10.80Spread

Pre-market

Jul 24, 2026 9:03:30 AM EDT

172.50USD-1.860%(-3.27)0

After-hours

Jul 24, 2026 4:00:30 PM EDT

175.77USD+0.011%(+0.02)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

17.75B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Jul 30, 2026 (3d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,102,320

Avg. Vol. 30 Day

1,163,510

Employees

470

Market Cap

17,747,625,024

Shares Out.

100,549,983

On/Off Exchange

57%/43%

6 Month Beta

0.76

1 Year Beta

0.69

2 Year Beta

0.80

3 Year Beta

0.71

52 Week Low

122.14

52 Week High

181.18

SMA50

165.31

SMA200

144.89

1 Week

+2.03%

1 Month

+4.74%

3 Month

+37.85%

6 Month

+31.83%

1 Year

+32.01%

2 Year

+20.24%

5 Year

+87.57%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $176.57, and today's volume is 432,643. NBIX is up 0.458% today. The 30 day average volume is 1,163,510. NBIX market cap is 17.75B with 100,549,983 shares outstanding.